Be a Smart Investor
Thursday, January 26, 2017
J&J, Actelion deal is great for pharma industry: Pro
John Rountree, managing partner at Novasecta, explains why J&J's acquisition of Actelion is "structured in a creative way."
from Mergers and Acquisitions http://ift.tt/2k6xmzi
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment